Anbio Biotechnology Balance Sheet (2023-2025) | NNNN

Balance Sheet Dec2023 Dec2024 Jun2025
Assets
Current Assets
Cash & Equivalents 0.01B0.01B5,348.49B
Short-term Investments 0.00B0.00B8,080.50B
Cash & Current Investments 0.01B0.01B13,428.99B
Receivables - Net 0.00B0.00B3,716.38B
Receivables 0.00B0.00B3,716.38B
Prepaid Assets 0.00B0.01B10,173.06B
Current Assets 0.02B0.02B27,680.59B
Non-Current Assets
Other Non-Current Assets 0.00B0.00B
Non-Current Assets 0.00B0.00B
Assets 0.02B0.02B27,680.59B
Liabilities
Current Liabilities
Accounts Payables 0.00B0.00B60.35B
Payables 0.00B0.00B60.35B
Accumulated Expenses 0.00B
Other Accumulated Expenses 0.00B0.00B
Total Current Liabilities 0.00B0.00B131.13B
Non-Current Liabilities
Total Liabilities 0.00B0.00B
Shareholder's Equity
Common Equity 0.01B0.02B27,549.47B
Shareholder's Equity 0.01B0.02B
Liabilities and Shareholders Equity 0.02B0.02B27,680.59B
Retained Earnings 0.01B0.02B20,971.45B